Carboxypeptidase M: A biomarker for the discrimination of well-differentiated liposarcoma from lipoma

Modern Pathology

Volumn 22, Issue 12, 2009, Pages 1541-1547

  Erickson Johnson, Michele R ^a   Seys, Amber R ^a   Roth, Christopher W ^a   King, Allison A ^a   Hulshizer, Rachael L ^a   Wang, Xiaoke ^a   Asmann, Yan W ^a   Lloyd, Ricardo V ^a   Jacob, Eapen K ^a   Oliveira, Andre M ^a  

^a MAYO CLINIC   (United States)

Author keywords

CPM; FISH; Lipoma; MDM2; Well differentiated liposarcoma

Indexed keywords

BIOLOGICAL MARKER; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; CYCLIN DEPENDENT KINASE 4; HIGH MOBILITY GROUP A2 PROTEIN; PROTEIN MDM2; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CHROMOSOME 12Q; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LIPOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

CELL DIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSIS, DIFFERENTIAL; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TESTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOMA; LIPOSARCOMA; METALLOENDOPEPTIDASES; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR MARKERS, BIOLOGICAL;

EID: 71149096889     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.149     Document Type: Article

References (23)

1. Jacob EK, Erickson-Johnson MR, Wang X, et al. Assessment of MDM2 amplification using fluorescence in situ hybridization of paraffin embedded tissues discriminates atypical lipomatous tumors from lipo-mas. Mod Pathol 2006;19(13A):45.
2. Sirvent N, Forus A, Lescaut W, et al. Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 2000;29:117-129.
3. Mef Nilbert AR, Felix M, Paul SM, et al. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 1995;83:32-36.
4. Nilsson M, Meza-Zepeda LA, Mertens F, et al. Amplification of chromosome 1 sequences in lipoma-tous tumors and other sarcomas. Int J Cancer 2004; 109:363-369.
5. Skubitz K, Cheng E, Clohisy D, et al. Differential gene expression in liposarcoma, lipoma, and adipose tissue. Cancer Invest 2005;23:105-118.
6. Pilotti S, Della Torre G, Lavarino C, et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 1997;181:14-24.
7. Weiss SW. Enzinger and Weiss's Soft Tissue Tumors 4th edn. Mosby: St Louis, MO, 2001.
8. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 2008;21:943-949.
9. Trahan S, Erickson-Johnson MR, Rodriguez F, et al. Formation of the 12q14-q15 amplicon precedes the development of a well-differentiated liposarcoma arising from a nonchondroid pulmonary hamartoma. Am J Surg Pathol 2006;30:1326-1329.
10. Fletcher C, Unni K, Mertens F, (eds) WHO Classification of Tumours; Pathology and Genetics: Tumours of Soft Tissue and Bone. IARC Press: Lyon, France, 2002.
11. Laurino L, Furlanetto A, Orvieto E, et al. Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol 2001;18:258-262.
12. Pedeutour F, Forus A, Coindre J, et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999;24:30-41.
13. Gisselsson D, Hoglund M, Mertens F, et al. The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet 1999; 104:315-325.
14. Borden E, Baker L, Bell R, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 2003;9:1941-1956.
15. Berner J, Forus A, Elkahloun A, et al. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 1996;17:254-259.
16. Ida CM WX, Erickson-Johnson MR, Wenger DE, et al. Primary retroperitoneal lipoma: a soft tissue pathology heresy?: report of a case with classic histologic, cytogenetics, and molecular genetic features. Am J Surg Pathol 2008;32:951-954.
17. Gustafson P, Akerman M, Alvegard T, et al. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system. Eur J Cancer 2003;39:1568-1576.
18. Nielsen T, West R, Linn S, et al. Molecular characterization of soft tissue tumours: a gene expression study. Lancet 2002;359:1301-1307.
19. Golub T, Slonim D, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
20. Helman L, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer 2003;3:685-694.
21. Fanburg-Smith JC, Miettinen M. Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with ded-ifferentiated liposarcoma. Histopathology 1998;33: 414-424.
22. Johnson MR, Seys AR, Roth CW, et al. Assessment of carboxypeptidase M (CPM) amplification: a surrogate marker for MDM2 amplification in the discrimination of well-differentiated liposarcomas from lipomas. ASHG Meeting Booklet. Phildelphia. Abstract 1190. 2008, p.246.
23. Deiteren K, Hendriks D, Scharpé S, et al. Carboxypep-tidase M: multiple alliances and unknown partners. Clinica Chimica Acta 2009;399:24-39.